Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Jean‐Marie Berthelot, Ludovic Drouet, Frédéric Lioté
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 1514-1522
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

COVID-19-associated vasculitis and vasculopathy
Richard C. Becker
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 3, pp. 499-511
Open Access | Times Cited: 278
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Juyan Zheng, Junluan Mo, Tao Zhu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 192
Signaling by cGAS–STING in Neurodegeneration, Neuroinflammation, and Aging
Bindu D. Paul, Solomon H. Snyder, Vilhelm A. Bohr
Trends in Neurosciences (2020) Vol. 44, Iss. 2, pp. 83-96
Open Access | Times Cited: 186
The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
Patrick Kwabena Oduro, Xianxian Zheng, Jinna Wei, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 50-75
Open Access | Times Cited: 162
Neutrophils in COVID-19: Not Innocent Bystanders
Ellen McKenna, Richard Wubben, Johana M. Isaza-Correa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 80
Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases
Jing Pan, Chen-Jie Fei, Yang Hu, et al.
动物学研究 (2023) Vol. 44, Iss. 1, pp. 183-218
Open Access | Times Cited: 43
STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion
Mina Yang, Haojie Jiang, Chen Ding, et al.
Immunity (2023) Vol. 56, Iss. 5, pp. 1013-1026.e6
Open Access | Times Cited: 43
Cardiovascular impact of COVID-19 with a focus on children: A systematic review
Moisés Rodríguez‐González, Ana Castellano‐Martínez, Helena María Cascales-Poyatos, et al.
World Journal of Clinical Cases (2020) Vol. 8, Iss. 21, pp. 5250-5283
Open Access | Times Cited: 122
Dysregulated Interferon Response Underlying Severe COVID-19
L. Espinoza López, Peter C. Sang, Yun Tian, et al.
Viruses (2020) Vol. 12, Iss. 12, pp. 1433-1433
Open Access | Times Cited: 84
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 59
Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation
Marion Pilard, Estelle L. Ollivier, Virginie Gourdou-Latyszenok, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 38
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection
Eugene Merzon, Ilan Green, Shlomo Vinker, et al.
FEBS Journal (2021) Vol. 288, Iss. 17, pp. 5179-5189
Open Access | Times Cited: 49
Systemic inflammatory syndrome in COVID-19–SISCoV study: systematic review and meta-analysis
Debjyoti Dhar, Treshita Dey, M. M. Samim, et al.
Pediatric Research (2021) Vol. 91, Iss. 6, pp. 1334-1349
Open Access | Times Cited: 46
Kawasaki Disease and COVID-19
Athanasios Gkoutzourelas, Dimitrios P. Bogdanos, Lazaros I. Sakkas
Mediterranean Journal of Rheumatology (2020) Vol. 31, Iss. Suppl 2, pp. 268-268
Open Access | Times Cited: 46
Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Jean-Marie Berthelot, Frédéric Lioté, Yves Maugars, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 46
Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
Gavriela Feketea, Vasiliki Vlacha, Ioana Corina Bocşan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
Rationales and uncertainties for aspirin use in COVID-19: a narrative review
Hazem A. Sayed Ahmed, Eric Merrell, Mansoura Ismail, et al.
Family Medicine and Community Health (2021) Vol. 9, Iss. 2, pp. e000741-e000741
Open Access | Times Cited: 32
Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Vasculitis Presented as Pulmonary Hemorrhage in a Positive COVID-19 Patient: A Case Report
Albadr Hussein, Khaled AL Khalil, Yasser Bawazir
Cureus (2020)
Open Access | Times Cited: 36
Immunogenetic Association Underlying Severe COVID-19
Kendall McCoy, Autumn Peterson, Yun Tian, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 700-700
Open Access | Times Cited: 33
Tanreqing Inhibits LPS-Induced Acute Lung Injury In Vivo and In Vitro Through Downregulating STING Signaling Pathway
Yu-Qiong He, Cancan Zhou, Jiuling Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
Coronary Vasculitis
Tommaso Gori
Biomedicines (2021) Vol. 9, Iss. 6, pp. 622-622
Open Access | Times Cited: 27
Vitamin D and COVID‐19: It is time to act
Andrius Bleizgys
International Journal of Clinical Practice (2020) Vol. 75, Iss. 3
Open Access | Times Cited: 29
High prevalence of occult thrombosis in cases of mild/moderate COVID-19
Budong Chen, Chunguo Jiang, Bing Han, et al.
International Journal of Infectious Diseases (2020) Vol. 104, pp. 77-82
Open Access | Times Cited: 28
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
Christian Devaux, Laurence Camoin‐Jau
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 16
An emerging natural antioxidant therapy for COVID‐19 infection patients: Current and future directions
Amit Kumar Shrivastava, Prafulla Kumar Sahu, Teresa Cecchi, et al.
Food Frontiers (2023) Vol. 4, Iss. 3, pp. 1179-1205
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top